The score is driven primarily by weak financial performance: ongoing unprofitability, negative operating cash flow, and high leverage outweigh moderate revenue growth and improving free cash flow growth. Technicals also pressure the score as the stock trades below all major moving averages with negative MACD, despite oversold readings (RSI/Stoch). Valuation provides limited support because the company is loss-making (negative P/E) and dividend yield is not available.
Positive Factors
Sustained Revenue Growth
Consistent revenue growth indicates ongoing demand for the company’s products and supports longer-term scale. Over a multi-quarter horizon, steady top-line expansion can enable reinvestment in R&D and sales, improving market position if managed alongside margin pressures.
Stable Gross Margin
A roughly 30% gross margin provides a structural cushion for the business model, enabling the company to cover operating expenses and pursue operating leverage as revenues grow. This margin level supports sustainable unit economics if cost control is maintained.
Improving Free Cash Flow
Material improvement in free cash flow growth and an FCF-to-net-income above 1 signal better cash conversion and liquidity on a structural basis. Over months, rising FCF reduces reliance on external funding and can fund strategic investments or deleveraging.
Negative Factors
Persistent Unprofitability
Ongoing negative net profit and EBIT margins indicate the business has not yet achieved operating profitability. Over a multi-quarter horizon this limits retained earnings, constrains reinvestment capacity, and increases reliance on external financing to sustain operations.
High Leverage and Weak ROE
A high debt-to-equity ratio combined with a deeply negative ROE signals significant financial risk and poor returns on capital. Structurally, this increases vulnerability to interest rate changes, refinancing risk, and limits strategic flexibility for M&A or capex.
Negative Operating Cash Flow
Persistent negative operating cash flow shows core operations do not generate sufficient cash, forcing dependence on debt or equity financing. Over several quarters this can strain liquidity, raise funding costs, and impede sustainable investment in growth initiatives.
Group 107 (G107) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪27.90M
Dividend YieldN/A
Average Volume (3M)60.21K
Price to Earnings (P/E)―
Beta (1Y)0.46
Revenue Growth26.93%
EPS Growth71.40%
CountryIL
Employees221
SectorServices
Sector StrengthN/A
IndustrySoftware - Infrastructure
Share Statistics
EPS (TTM)-0.80
Shares Outstanding29,342,375
10 Day Avg. Volume39,586
30 Day Avg. Volume60,213
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)23.23
Price to Sales (P/S)0.35
P/FCF Ratio-22.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Group 107 Business Overview & Revenue Model
Company DescriptionGroup 107 Ltd. provides software solutions and services in Israel. The company offers Levent, a cloud-based solution designed to work as an algo-trading system for banks, hedge funds, and brokers; and Borsa Live, a real time stocks tracking app. It also provides IT outsourcing services in the areas of clickable prototypes, AWS hosting as a service, DevOps, cyber security, artificial intelligence, blockchain, bigdata, Internet of things, business intelligence, and data science, as well as supplies offshore software development teams. The company is based in Tel Aviv, Israel.
How the Company Makes MoneyG107 generates revenue through multiple streams, primarily from the sale of its software applications and medical devices, which are marketed to both businesses and consumers. The company also earns income from long-term contracts with healthcare institutions and government agencies for the provision of advanced medical technology and support services. Additionally, G107 has established strategic partnerships with key players in the renewable energy sector, allowing it to monetize its innovations in sustainable energy solutions through licensing agreements and joint ventures. These partnerships not only enhance G107's market reach but also provide additional revenue through shared projects and collaborative research initiatives.
Group 107 Financial Statement Overview
Summary
Moderate revenue growth (6.44% TTM) and improving free cash flow growth (43.58% TTM) are positives, but overall fundamentals are weak due to persistent losses (negative net profit/EBIT margins), high leverage (debt-to-equity 2.74 TTM), very negative ROE (-88.55% TTM), and negative operating cash flow.
Income Statement
45
Neutral
Group 107 shows a moderate revenue growth rate of 6.44% TTM, but profitability remains a concern with negative net profit and EBIT margins. The gross profit margin is relatively stable at 30.48% TTM, indicating some efficiency in cost management. However, the consistent negative net income highlights ongoing challenges in achieving profitability.
Balance Sheet
30
Negative
The company's balance sheet reveals high leverage with a debt-to-equity ratio of 2.74 TTM, indicating significant reliance on debt financing. The negative return on equity of -88.55% TTM suggests that the company is not generating sufficient returns on shareholder investments. The equity ratio is not provided, but the high debt levels pose a risk to financial stability.
Cash Flow
40
Negative
Cash flow analysis shows improvement in free cash flow growth at 43.58% TTM, but operating cash flow remains negative, indicating cash management challenges. The free cash flow to net income ratio of 1.21 TTM suggests that cash generation is better than net income figures, yet the negative operating cash flow coverage ratio points to potential liquidity issues.
Breakdown
TTM
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Income Statement
Total Revenue
38.46M
33.81M
30.36M
29.20M
16.18M
7.11M
Gross Profit
11.72M
8.84M
6.44M
5.20M
4.45M
2.51M
EBITDA
386.00K
-148.00K
-2.94M
-6.75M
-10.88M
-1.62M
Net Income
-588.00K
-1.33M
-3.88M
-8.12M
-10.22M
-802.00K
Balance Sheet
Total Assets
11.30M
11.32M
4.07M
6.71M
12.94M
621.00K
Cash, Cash Equivalents and Short-Term Investments
912.00K
1.77M
1.02M
1.85M
10.56M
92.00K
Total Debt
2.24M
1.82M
1.31M
1.58M
1.14M
2.27M
Total Liabilities
9.01M
9.04M
5.26M
5.53M
3.74M
4.19M
Stockholders Equity
819.00K
509.00K
-1.20M
1.18M
9.20M
-3.57M
Cash Flow
Free Cash Flow
-1.34M
-525.00K
-1.74M
-7.73M
-9.17M
-614.00K
Operating Cash Flow
-1.10M
-436.00K
-1.71M
-7.30M
-7.75M
-385.00K
Investing Cash Flow
-4.00K
842.00K
53.00K
-504.00K
-1.65M
-229.00K
Financing Cash Flow
-869.00K
335.00K
939.00K
-918.00K
19.64M
721.00K
Group 107 Technical Analysis
Technical Analysis Sentiment
Positive
Last Price126.20
Price Trends
50DMA
111.23
Positive
100DMA
200DMA
Market Momentum
MACD
2.87
Positive
RSI
56.50
Neutral
STOCH
52.82
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:G107, the sentiment is Positive. The current price of 126.2 is above the 20-day moving average (MA) of 117.25, above the 50-day MA of 111.23, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 2.87 indicates Positive momentum. The RSI at 56.50 is Neutral, neither overbought nor oversold. The STOCH value of 52.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:G107.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 20, 2026